Delisting of securities of phasebio pharmaceuticals, inc.; zovio inc.; fast radius, inc.; and kismet acquisition three corp. from the nasdaq stock market

New york, dec. 20, 2022 (globe newswire) -- the nasdaq stock market announced today that it will delist the common stock of phasebio pharmaceuticals, inc. phasebio pharmaceuticals, inc.'s common stock was suspended on november 3, 2022, and has not traded on nasdaq since that time.

NDAQ Ratings Summary

NDAQ Quant Ranking